Complete financial analysis of WeLeader Biomedical Co., Ltd. (7713.TWO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of WeLeader Biomedical Co., Ltd., a leading company in the None industry within the None sector.
You may be interested
- BriaCell Therapeutics Corp. (BCTX) Income Statement Analysis – Financial Results
- Pharmanutra S.p.A. (PHN.MI) Income Statement Analysis – Financial Results
- Coal India Limited (COALINDIA.NS) Income Statement Analysis – Financial Results
- AH-Vest Limited (AHL.JO) Income Statement Analysis – Financial Results
- Better Choice Company Inc. (BTTR) Income Statement Analysis – Financial Results
WeLeader Biomedical Co., Ltd. (7713.TWO)
| Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 940.70M | 1.04B | 841.14M | 674.55M |
| Cost of Revenue | 642.62M | 743.97M | 622.22M | 517.95M |
| Gross Profit | 298.08M | 291.75M | 218.92M | 156.60M |
| Gross Profit Ratio | 31.69% | 28.17% | 26.03% | 23.22% |
| Research & Development | 0.00 | 0.00 | 0.00 | 3.99M |
| General & Administrative | 69.05M | 69.40M | 63.85M | 0.00 |
| Selling & Marketing | 31.54M | 28.24M | 22.41M | 17.74M |
| SG&A | 100.59M | 97.64M | 86.26M | 17.74M |
| Other Expenses | 197.49M | 1.88M | 5.27M | 1.24M |
| Operating Expenses | 298.08M | 97.64M | 86.26M | 88.63M |
| Cost & Expenses | 940.70M | 841.61M | 708.48M | 606.57M |
| Interest Income | 592.00K | 235.00K | 75.00K | 74.00K |
| Interest Expense | 5.69M | 4.21M | 6.16M | 8.59M |
| Depreciation & Amortization | 103.80M | 109.82M | 114.44M | 109.36M |
| EBITDA | 303.04M | 306.57M | 252.06M | 179.22M |
| EBITDA Ratio | 32.21% | 29.55% | 30.01% | 26.48% |
| Operating Income | 197.49M | 196.22M | 132.28M | 68.56M |
| Operating Income Ratio | 20.99% | 18.95% | 15.73% | 10.16% |
| Total Other Income/Expenses | -3.94M | -3.68M | -818.00K | -7.28M |
| Income Before Tax | 193.55M | 192.55M | 131.46M | 61.28M |
| Income Before Tax Ratio | 20.57% | 18.59% | 15.63% | 9.08% |
| Income Tax Expense | 41.26M | 38.75M | 25.69M | 12.20M |
| Net Income | 152.28M | 153.80M | 105.77M | 49.08M |
| Net Income Ratio | 16.19% | 14.85% | 12.57% | 7.28% |
| EPS | 4.36 | 4.40 | 3.79 | 1.18 |
| EPS Diluted | 3.66 | 4.34 | 3.76 | 1.18 |
| Weighted Avg Shares Out | 34.95M | 34.95M | 27.88M | 41.58M |
| Weighted Avg Shares Out (Dil) | 41.58M | 35.44M | 28.10M | 41.58M |
No news found for: 7713.TWO
Source: https://incomestatements.info
Category: Stock Reports